B7-H3作为肺癌治疗靶点的吸引力。
The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment.
作者信息
Papavassiliou Kostas A, Sofianidi Amalia A, Papavassiliou Athanasios G
机构信息
First University Department of Respiratory Medicine, 'Sotiria' Chest Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
出版信息
Cancers (Basel). 2025 May 1;17(9):1546. doi: 10.3390/cancers17091546.
Abstract
In 2015, the U [...].
摘要
2015年，美国[……]。 （你提供的原文不完整，我只能翻译到这里。请补充完整原文，以便我给出更准确的译文。）
相似文献
1
The Attractiveness of B7-H3 as a Target for Lung Cancer Treatment.B7-H3作为肺癌治疗靶点的吸引力。
Cancers (Basel). 2025 May 1;17(9):1546. doi: 10.3390/cancers17091546.
2
B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma.B7-H3促进肺腺癌的转移、增殖和上皮-间质转化。
Onco Targets Ther. 2018 Aug 10;11:4693-4700. doi: 10.2147/OTT.S169811. eCollection 2018.
3
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.肺癌患者接受各种抗癌治疗后B7-H3表达的免疫组织化学分析。
Invest New Drugs. 2023 Apr;41(2):356-364. doi: 10.1007/s10637-023-01353-8. Epub 2023 Apr 10.
4
B7-H3, a checkpoint molecule, as a target for cancer immunotherapy.B7-H3，一种检查点分子，可作为癌症免疫治疗的靶点。
Int J Biol Sci. 2020 Mar 25;16(11):1767-1773. doi: 10.7150/ijbs.41105. eCollection 2020.
5
B7-H3 Associates with IMPDH2 and Regulates Cancer Cell Survival.B7-H3与肌苷酸脱氢酶2相关并调节癌细胞存活。
Cancers (Basel). 2023 Jul 7;15(13):3530. doi: 10.3390/cancers15133530.
6
The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.肺癌恶性胸腔积液患者中 B7-H3 和 miR-145 的表达及临床意义。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6759-6766. doi: 10.26355/eurrev_202006_21664.
7
High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis.肿瘤微环境中单核细胞/巨噬细胞上B7-H3的高表达通过抑制细胞凋亡促进肺癌进展。
Transl Oncol. 2024 Mar;41:101874. doi: 10.1016/j.tranon.2023.101874. Epub 2024 Jan 22.
8
Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.B7-H3 表达对非小细胞肺癌肿瘤浸润免疫细胞及临床病理特征的影响。
Eur J Cancer. 2020 Jul;133:74-85. doi: 10.1016/j.ejca.2020.03.033. Epub 2020 May 21.
9
B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN.B7-H3通过SREBP1介导的脂肪酸合酶（FASN）表达来调节肺癌的脂质代谢。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1246-1251. doi: 10.1016/j.bbrc.2016.12.021. Epub 2016 Dec 7.
10
B7-H3 promotes proliferation and migration of lung cancer cells by modulating PI3K/AKT pathway via ENO1 activity.B7-H3通过ENO1活性调节PI3K/AKT通路促进肺癌细胞的增殖和迁移。
Transl Cancer Res. 2024 Feb 29;13(2):833-846. doi: 10.21037/tcr-23-1537. Epub 2024 Feb 15.
本文引用的文献
1
Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical Applications.靶向B7-H3的肿瘤免疫疗法：从作用机制到临床应用
Immunotargets Ther. 2025 Mar 27;14:291-320. doi: 10.2147/ITT.S507522. eCollection 2025.
2
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.泛癌分析 B7-H3（CD276）作为人类恶性肿瘤中一种可行的治疗靶点。
Cancer Res Commun. 2024 May 30;4(5):1369-1379. doi: 10.1158/2767-9764.CRC-23-0546.
3
High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis.肿瘤微环境中单核细胞/巨噬细胞上B7-H3的高表达通过抑制细胞凋亡促进肺癌进展。
Transl Oncol. 2024 Mar;41:101874. doi: 10.1016/j.tranon.2023.101874. Epub 2024 Jan 22.
4
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.非小细胞肺癌免疫治疗获得性耐药的临床和分子特征。
Cancer Cell. 2024 Feb 12;42(2):209-224.e9. doi: 10.1016/j.ccell.2023.12.013. Epub 2024 Jan 11.
5
B7-H3/CD276 and small-cell lung cancer: What's new?B7-H3/CD276与小细胞肺癌：有哪些新进展？
Transl Oncol. 2024 Jan;39:101801. doi: 10.1016/j.tranon.2023.101801. Epub 2023 Oct 20.
6
B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.靶向 B7H3 的金纳米笼 pH 敏感偶联物用于 NSCLC 的精确协同化学生物治疗。
J Nanobiotechnology. 2023 Oct 17;21(1):378. doi: 10.1186/s12951-023-02078-9.
7
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.肺癌患者接受各种抗癌治疗后B7-H3表达的免疫组织化学分析。
Invest New Drugs. 2023 Apr;41(2):356-364. doi: 10.1007/s10637-023-01353-8. Epub 2023 Apr 10.
8
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development.免疫检查点 B7-H3（CD276）研究和药物开发的新前沿。
Mol Cancer. 2023 Mar 2;22(1):43. doi: 10.1186/s12943-023-01751-9.
9
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.西妥昔单抗联合化疗对比单纯化疗治疗非小细胞肺癌：一项随机、对照、双盲的 3 期临床试验。
Nat Med. 2022 Nov;28(11):2374-2380. doi: 10.1038/s41591-022-01977-y. Epub 2022 Aug 25.
10
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.双 checkpoint 靶向药物恩沃利单抗联合帕博利珠单抗治疗晚期实体瘤：来自多中心 I/II 期试验的初步结果。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-004424.
Zotero 插件